Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

A shortcut to mean-based time tradeoff tariffs for the EQ-5D?

Rand-Hendriksen K, Augestad LA, Dahl FA, Kristiansen IS, Stavem K.

Med Decis Making. 2012 Jul-Aug;32(4):569-77. doi: 10.1177/0272989X11431607. Epub 2012 Jan 12.

PMID:
22247424
2.

Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory study.

Ludwig K, von der Schulenburg JG, Greiner W.

Health Qual Life Outcomes. 2017 Feb 20;15(1):39. doi: 10.1186/s12955-017-0617-9.

3.

Inconsistencies in TTO and VAS values for EQ-5D health states.

Lamers LM, Stalmeier PF, Krabbe PF, Busschbach JJ.

Med Decis Making. 2006 Mar-Apr;26(2):173-81.

PMID:
16525171
4.

Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.

Shiroiwa T, Ikeda S, Noto S, Igarashi A, Fukuda T, Saito S, Shimozuma K.

Value Health. 2016 Jul-Aug;19(5):648-54. doi: 10.1016/j.jval.2016.03.1834. Epub 2016 Apr 26.

5.

How different are composite and traditional TTO valuations of severe EQ-5D-5L states?

Xie F, Pullenayegum E, Gaebel K, Bansback N, Bryan S, Ohinmaa A, Poissant L, Johnson JA.

Qual Life Res. 2016 Aug;25(8):2101-8. doi: 10.1007/s11136-016-1242-5. Epub 2016 Feb 13.

PMID:
26875190
6.

Preparatory study for the revaluation of the EQ-5D tariff: methodology report.

Mulhern B, Bansback N, Brazier J, Buckingham K, Cairns J, Devlin N, Dolan P, Hole AR, Kavetsos G, Longworth L, Rowen D, Tsuchiya A.

Health Technol Assess. 2014 Feb;18(12):vii-xxvi, 1-191. doi: 10.3310/hta18120.

7.

Quality-of-life valuations of advanced breast cancer by New Zealand women.

Milne RJ, Heaton-Brown KH, Hansen P, Thomas D, Harvey V, Cubitt A.

Pharmacoeconomics. 2006;24(3):281-92.

PMID:
16519549
8.

A comparison of individual and social time trade-off values for health states in the general population.

Burström K, Johannesson M, Diderichsen F.

Health Policy. 2006 May;76(3):359-70. Epub 2005 Oct 7.

PMID:
16214258
9.

[Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff].

Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ.

Ned Tijdschr Geneeskd. 2005 Jul 9;149(28):1574-8. Dutch.

PMID:
16038162
10.

[General population time trade-off values for 42 EQ-5D health states in South Korea].

Jo MW, Lee SI.

J Prev Med Public Health. 2007 Mar;40(2):169-76. Korean.

PMID:
17426430
11.

Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.

Ariza-Ariza R, Hernández-Cruz B, Carmona L, Dolores Ruiz-Montesinos M, Ballina J, Navarro-Sarabia F; Costs and Quality of Life in Rheumatoid Arthritis Study Group.

Arthritis Rheum. 2006 Oct 15;55(5):751-6.

12.

Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.

Bernert S, Fernández A, Haro JM, König HH, Alonso J, Vilagut G, Sevilla-Dedieu C, de Graaf R, Matschinger H, Heider D, Angermeyer MC; ESEMeD/MHEDEA 2000 Investigators.

Value Health. 2009 Jul-Aug;12(5):750-8. doi: 10.1111/j.1524-4733.2009.00509.x.

13.

Dutch Tariff for the Five-Level Version of EQ-5D.

M Versteegh M, M Vermeulen K, M A A Evers S, de Wit GA, Prenger R, A Stolk E.

Value Health. 2016 Jun;19(4):343-52. doi: 10.1016/j.jval.2016.01.003. Epub 2016 Mar 30.

15.

Learning effects in time trade-off based valuation of EQ-5D health states.

Augestad LA, Rand-Hendriksen K, Kristiansen IS, Stavem K.

Value Health. 2012 Mar-Apr;15(2):340-5. doi: 10.1016/j.jval.2011.10.010. Epub 2012 Jan 27.

16.

Utility assessment in patients with mental disorders: validity and discriminative ability of the time trade-off method.

König HH, Günther OH, Angermeyer MC, Roick C.

Pharmacoeconomics. 2009;27(5):405-19. doi: 10.2165/00019053-200927050-00005.

PMID:
19586078
17.

Lead time TTO: leading to better health state valuations?

Attema AE, Versteegh MM, Oppe M, Brouwer WB, Stolk EA.

Health Econ. 2013 Apr;22(4):376-92. doi: 10.1002/hec.2804. Epub 2012 Mar 6.

PMID:
22396243
18.

Inconsistent responses in three preference-elicitation methods for health states.

Badia X, Roset M, Herdman M.

Soc Sci Med. 1999 Oct;49(7):943-50.

PMID:
10468398
19.

Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states.

Rand-Hendriksen K, Augestad LA.

Value Health. 2012 Jul-Aug;15(5):777-82. doi: 10.1016/j.jval.2012.04.002. Epub 2012 Jun 7.

20.

Validity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore population.

Au Eong KG, Chan EW, Luo N, Wong SH, Tan NW, Lim TH, Wagle AM.

Eye (Lond). 2012 Mar;26(3):379-88. doi: 10.1038/eye.2011.218. Epub 2012 Jan 6.

Supplemental Content

Support Center